Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Nguyen Dang (Liege, Belgium), J. Guiot (Liege, Belgium), C. Graas (Liege, Belgium), H. Van Cauwenberge (Liege, Belgium), J. Corhay (Liege, Belgium), R. Louis (Liege, Belgium). Effects of a 6-months comprehensive pulmonary rehabilitation program (CPRP) in patients with diffuse interstitial lung diseases (ILD). 679

Member's Comments

No comment yet.

Related content which might interest you: Effects of pulmonary rehabilitation in patients with interstitial lung disease (ILD) Source: Annual Congress 2009 - New treatment and outcome measures for pulmonary rehabilitation Year: 2009 Effect of an 8 week pulmonary rehabilitation program in patients with interstitial lung diseases in India. Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? Year: 2018 Pulmonary rehabilitation (PR) exercise tolerance improvement: Differences between interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions Year: 2013 Pulmonary rehabilitation (PR) outcomes in chronic obstructive pulmonary disease (COPD) compared with interstitial lung disease (ILD) Source: Annual Congress 2011 - Pulmonary rehabilitation: looking at alternative approaches and alternative populations beyond COPD Year: 2011 Effects of pulmonary rehabilitation in patients with severe COPD in comparison to patients with severe interstitial lung disease Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation Year: 2013 Benefits of pulmonary rehabilitation (PR) in patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) having the same dyspnoea severity Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? Year: 2018 Effects of a combination of pulmonary rehabilitation (PR) and non invasive ventilation (NIV) in patients with advanced interstitial lung disease (ILD) Source: Annual Congress 2009 - Noninvasive ventilation in chronic respiratory failure Year: 2009 Diffuse lung disease in infancy: a working classification of the pediatric interstitial lung disease (pILD) multidisciplinary cooperative group Source: Eur Respir J 2005; 26: Suppl. 49, 500s Year: 2005 Effects of inpatient pulmonary rehabilitation in patients with interstitial lung disease Source: Eur Respir J 2013; 42: 444-453 Year: 2013 The role of secondary pulmonary hypertension (SPH) in the limited exercise tolerance of patients with interstitial lung disease (ILD) Source: Eur Respir J 2005; 26: Suppl. 49, 560s Year: 2005 Interstitial lung diseases: is there a place for a rehabilitation program? Source: Annual Congress 2005 - PG15 - Therapeutic options for interstitial lung diseases in 2005 Year: 2005 Are there differences in response to pulmonary rehabilitation (PR) in idiopathic pulmonary fibrosis (IPF) and COPD patients? Source: International Congress 2017 – New insights into pulmonary rehabilitation in patients with chronic lung diseases Year: 2017 Effectiveness of a community based pulmonary rehabilitation (PR) programme for patients with chronic obstructive pulmonary disease (COPD): A retrospective review Source: International Congress 2017 – Best abstracts in pulmonary rehabilitation in patients with chronic lung diseases Year: 2017 Effects of a home-based pulmonary rehabilitation program in patients with chronic obstructive pulmonary disease of GOLD D group. Source: Virtual Congress 2021 – Pulmonary rehabilitation in the COVID-19 era Year: 2021 Exercise training in patients with interstitial lung disease (ILD): Can reponders be distinguished from non-responders Source: International Congress 2015 – Effects of rehabilitation, exercise, physical activity, hospitalisation and surgery on different conditions Year: 2015 Patients profile and pulmonary rehabilitation in interstitial lung disease Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care Year: 2018 Benefit of treatment with pirfenidone (PFD) persists over time in patients with idiopathic pulmonary fibrosis (IPF) with limited lung function impairment Source: International Congress 2016 – IPF treatment I Year: 2016 Outcome differences between idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILD) - data from the EXCITING registry Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 Impact of bisphosphonate (BP) use on lung function decline and treatment response in patients (pts) with idiopathic pulmonary fibrosis (IPF) Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis Year: 2020 Functional status following pulmonary rehabilitation in patients with interstitial lung disease Source: Virtual Congress 2021 – Peripheral muscle function, exercise capacity and functional status in respiratory disease Year: 2021